An Exosomal microRNA Signature for Preoperative Staging in Colon Cancer

计划入组 400 人 · 首次发布于 2025 年 12 月 1 日

PREDICT Therapy Selection for JAK, T-cell, or IL-6 Inhibitor Therapies Using a Molecular Signature Response Classifier (PREDICT)

计划入组 1,100 人 · 首次发布于 2024 年 4 月 30 日

Establishment of a Signature of Circulating microRNA as a Tool to Aid Diagnosis of Primary Brain Tumors in Adults

计划入组 160 人 · 首次发布于 2018 年 8 月 15 日

SIG001 (Signature Biologics)

microRNA-124

MicroRNA-29

Signature Therapeutics, Inc.

United States

SIGNATURE PHYTOCHEMICAL INDUSTRIES

India

Micron Technology

AccuStem's MSC Blood Test Set to Transform Lung Cancer Screening in the US

Interpace Biosciences Secures US Patent for MicroRNA Technology in Thyroid Cancer Diagnosis

Biocartis and City of Hope Partner to Develop Rapid Blood-Based Gene Signature Test for Early Pancreatic Cancer Detection